These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 31151913

  • 21. Passage Adaptation Correlates With the Reduced Efficacy of the Influenza Vaccine.
    Chen H, Alvarez JJS, Ng SH, Nielsen R, Zhai W.
    Clin Infect Dis; 2019 Sep 13; 69(7):1198-1204. PubMed ID: 30561532
    [Abstract] [Full Text] [Related]

  • 22. Predictability of antigenic evolution for H3N2 human influenza A virus.
    Suzuki Y.
    Genes Genet Syst; 2013 Sep 13; 88(4):225-32. PubMed ID: 24463525
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR, Cheng CY, Chen CY, Lin CH, Kuo CY, Huang HY, Wu FT, Yang YC, Wu CY, Liu MT, Hsiao PW.
    Antiviral Res; 2017 Apr 13; 140():62-75. PubMed ID: 28093338
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
    Wen F, Li L, Zhao N, Chiang MJ, Xie H, Cooley J, Webby R, Wang PG, Wan XF.
    J Virol; 2018 Jan 15; 92(2):. PubMed ID: 29118117
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
    Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ.
    Science; 2013 Nov 22; 342(6161):976-9. PubMed ID: 24264991
    [Abstract] [Full Text] [Related]

  • 38. Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept.
    Erdman MM, Kamrud KI, Harris DL, Smith J.
    Vaccine; 2010 Jan 08; 28(3):594-6. PubMed ID: 19853679
    [Abstract] [Full Text] [Related]

  • 39. Distinct molecular evolution of influenza H3N2 strains in the 2016/17 season and its implications for vaccine effectiveness.
    Kim JI, Park S, Chu H, Lee I, Bae JY, Yoo K, Kim J, Lee JY, Lee N, Kim M, Kim JS, Hong KW, Jun KR, Lee JN, Kim K, Park MS.
    Mol Phylogenet Evol; 2019 Feb 08; 131():29-34. PubMed ID: 30399431
    [Abstract] [Full Text] [Related]

  • 40. N-Glycosylation of Seasonal Influenza Vaccine Hemagglutinins: Implication for Potency Testing and Immune Processing.
    An Y, Parsons LM, Jankowska E, Melnyk D, Joshi M, Cipollo JF.
    J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30355697
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.